Business ❯Finance ❯Corporate Finance ❯Pharmaceuticals

Novo Nordisk

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns